-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

BRIEF-Abbvie - Reported GAAP Earnings And Adjusted Earnings For Q4 Are Expected To Include Acquired Ipr&D And Milestones Expense Of $243 Million On A Pre-Tax Basis

Reuters · 01/06/2023 16:24
BRIEF-Abbvie - Reported GAAP Earnings And Adjusted Earnings For Q4 Are Expected To Include Acquired Ipr&D And Milestones Expense Of $243 Million On A Pre-Tax Basis

- Abbvie Inc ABBV.N:

  • ABBVIE - REPORTED GAAP EARNINGS AND ADJUSTED EARNINGS FOR Q4 ARE EXPECTED TO INCLUDE ACQUIRED IPR&D AND MILESTONES EXPENSE OF $243 MILLION ON A PRE-TAX BASIS

  • 2022 ADJUSTED DILUTED EPS GUIDANCE RANGE, INCLUDING IMPACT OF FOURTH QUARTER 2022 ACQUIRED IPR&D AND MILESTONES EXPENSE, IS $13.70 - $13.74

  • Q4 2022 ADJUSTED EARNINGS PER SHARE GUIDANCE RANGE, INCLUDING IMPACT OF Q4 2022 ACQUIRED IPR&D AND MILESTONES EXPENSE, IS $3.51 - $3.55

  • DOES NOT FORECAST ACQUIRED IPR&D AND MILESTONES EXPENSE DUE TO UNCERTAINTY OF FUTURE OCCURRENCE AND TIMING OF THESE TRANSACTIONS

  • Q4 EARNINGS PER SHARE VIEW $3.67 -- REFINITIV IBES DATA

Further company coverage: ABBV.N


((Reuters.Briefs@thomsonreuters.com;;))